NMTC NeuroOne Medical Technologies
NeuroOne Medical Technologies earnings company data as of 4:51 AM ET 10/23
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 15 Dec | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q3 | 13 Aug | EPS | — | -0.23 | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by NMTC's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $737K bought by 1 insider
- $55K sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
David J. Wambeke Chief Business OfficerBuy$67K 33,333 shares at $2.01 +20% to stakeTraded Aug 27 Filed Sep 8
-
Mark Christianson Market Development DirectorSale$32K 10,000 shares at $3.18 33% of stakeTraded Jun 30 Filed Jul 2
-
Mark Christianson Business Development DirectorSale$11K 15,363 shares at $0.7400 7.2% of stakeTraded Mar 30 Filed Apr 1
-
Mark Christianson Business Development DirectorSale$734 917 shares at $0.8000 0.4% of stakeTraded Mar 12–13 Filed Mar 16
-
Mark Christianson Business Development DirectorSale$11K 13,720 shares at $0.8000 6% of stakeTraded Mar 10–11 Filed Mar 12
-
David J. Wambeke Chief Business OfficerBuy$670K 1,000,000 shares at $0.6700 New stakeTraded Mar 1 Filed Mar 3
Also filed in the last 12 months, not counted as buying or selling: 9 share withholdings for taxes and 5 stock grants.
SEC filings
Recent issuer filings from EDGAR, 20 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02,8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q/A | AMENDMENT NO. 1 TO FORM 10-Q | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 424B5 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 8-K | 4.02,7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 5.03,9.01 | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| DEF 14A | PROXY STATEMENT | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.